SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 15th, 2011 • Novadel Pharma Inc • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 14, 2011, is by and among NovaDel Pharma Inc., a Delaware corporation with headquarters located at 1200 Route 22 East, Suite 2000, Bridgewater, New Jersey 08807 (the ”Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
FORM OF SERIES B WARRANT] NOVADEL PHARMA INC. WARRANT TO PURCHASE COMMON STOCKWarrant to Purchase Common Stock • February 15th, 2011 • Novadel Pharma Inc • Pharmaceutical preparations • New York
NovaDel Pharma Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [IROQUOIS MASTER FUND LTD.], [OTHER BUYERS], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”), at any time or times on or after the Issuance Date, but not after 11:59 p.m., New York time, on the Expiration Date (as defined below), [______________]1 (subject to adjustment as provided herein) fully paid and non-assessable shares of Common Stock (as defined below) (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanings set f
